Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser Assisted Drug Delivery of NanoDOX® in Healthy Subjects
NCT05411484Phase 2Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Nov 2023
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in wound, sponsored by Massachusetts General Hospital. Started Nov 2023; status: active, not recruiting.
02
Drugs
doxycycline
03
Conditions
wound
Beyond the preview
Go deeper on NCT05411484.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05411484.